Senseonics Holdings, Inc. — fact timeline

Senseonics Holdings, Inc.: Increased authorized shares of common stock from 70,000,000 to 140,000,000 (effective 2026-05-20).

“the Company filed the Amendment with the Secretary of State of the State of Delaware.”

Senseonics Holdings, Inc. amended Second Amendment to Loan and Security Agreement with Hercules Capital, Inc. and the Lenders valued at up to $140.0 million (effective 2026-05-01).

“On May 1, 2026, Senseonics Holdings, Inc. (the “Company”) together with several of its wholly-owned subsidiaries (collectively, “Senseonics”) entered into a Second Amendment to Loan and Security Agreement (the “Second Amendment”) with the several financial institutions or entities party thereto (collectively, the “Lenders”) and Hercules Capital, Inc., a Maryland corporation (the “Agent”), in its capacity as administrative agent and collateral agent for itself and the Lenders, which further amends the Company’s existing Loan and Security Agreement”

Senseonics Holdings, Inc. incurred term loan of $10.0 million with Hercules Capital, Inc. at the greater of (i) the prime rate as reported in The Wall Street Journal plus 2. maturing September 3, 2029.

“a term loan of $10.0 million to be funded at the closing of the Second Amendment (the “Tranche 2 Loan”)”

Senseonics Holdings, Inc. reported the quarter ended March 31, 2026 results: revenue approximately $11.7 million.

“Although the Company has not finalized its full financial results for the quarter ended March 31, 2026, it expects to report the following selected financial information as of and for the quarter ended March 31, 2026: · revenue of approximately $11.7 million; · gross profit of approximately $6.4 million; · gross margin of approximately 54%; · net loss between $31 million and $33 million; · cash, cash equivalents, short-term investments and restricted cash of approximately $64.6 million; · stockholders’ equity of between $33.7 million and $35.7 million.”

Senseonics Holdings, Inc. entered into Local Asset Purchase Agreements with Ascensia Diabetes Care Holdings AG valued at Cash payment of respective Net Book Value (effective 2026-03-12).

“On March 12, 2026, the Purchaser Parties and the Seller Parties entered into the Local Purchase Agreements, pursuant to which, among other things, the Purchaser Parties agreed to acquire Seller’s and as applicable, Seller Parties’, right, title and interest in and to the European Purchased Assets and to assume the European Assumed Liabilities, as contemplated by the Master Asset Purchase Agreement.”

Senseonics Holdings, Inc. amended Amended and Restated Collaboration and Commercialization Agreement with Ascensia Diabetes Care Holdings AG (effective 2025-12-31).

“In connection with entering into the Master Asset Purchase Agreement, Senseonics Inc. and the Seller entered into an Amended and Restated Collaboration and Commercialization Agreement (the “ A&R Collaboration Agreement ”) on the Execution Date, which amended and restated that certain Collaboration and Commercialization Agreement, dated August 9, 2020, between Senseonics Inc. and the Seller, as amended to date (the “ Existing Agreement ”).”

Senseonics Holdings, Inc. entered into Master Asset Purchase Agreement with Ascensia Diabetes Care Holdings AG valued at approximately $1.1 million (effective 2025-12-31).

“On December 31, 2025 (the “ Execution Date ”), Senseonics Holdings, Inc. (the “ Company ”), Senseonics, Incorporated, a wholly-owned subsidiary of the Company (“ Senseonics Inc. ” and together with the Company, the “ Purchaser Parties ”) and Ascensia Diabetes Care Holdings AG (the “ Seller ”) entered into a master asset purchase agreement (the “ Master Asset Purchase Agreement ”), pursuant to which, among other things, the Purchaser Parties agreed to acquire Seller’s and as applicable, Seller’s affiliates’, right, title and interest in and to certain assets related Seller’s marketing, selling and distribution of the Eversense® product in the United States”

Senseonics Holdings, Inc.: Amended certificate of incorporation to effect 1-for-20 reverse stock split and reduce authorized shares from 1,400,000,000 to 70,000,000 (effective 2025-10-17).

“On October 16, 2025, Senseonics Holdings, Inc. (the “Company”) filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the “Amendment”) with the Secretary of State of the State of Delaware to effect the previously disclosed one-for-twenty (1-for-20) reverse stock split (the “Reverse Stock Split”) of its outstanding common stock and a proportional decrease in the total number of authorized shares of its common stock from 1,400,000,000 to 70,000,000 (the “Shares Reduction”).”

Senseonics Holdings, Inc. amended credit facility of up to $100.0 million in senior secured term loans, consisting of (i) an initial term loan of $35.0 million, which was fu with Hercules Capital, Inc. at annual rate equal to the greater of (i) the prime rate as reported in The Wall S maturing September 3, 2029.

“among the Company, Senseonics Inc., certain of the Lenders and the Agent. Pursuant to the Amended Loan Agreement, the Lenders have agreed to make available to Senseonics up to $100.0 million in senior secured term loans, consisting of (i) an initial term loan of $35.0 million, which was funded on the Effective Date to refinance the outstanding term loans under the”

Anthony Raab resigned as Director at Senseonics Holdings, Inc..

“On January 17, 2025, Anthony Raab, a director of Senseonics Holdings, Inc. (the “Company”) notified the Board of Directors of the Company (the “Board”) of his resignation from the Board effective as of January 17, 2025, in order to focus on his time commitments to his professional investment career, other board roles and family.”

Senseonics Holdings, Inc. reported quarter ended March 31, 2024 results: revenue $5.1 million, net income Net loss was $18.9 million, or $0.03 per share, EPS $0.03 per share.

“Total revenue for the first quarter of 2024 was $5.1 million compared to $4.1 million for the first quarter of 2023.”